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SurveillanceWe have studied the occurrence of hBoV, hMPV and InfA-B in an Apulian population with respiratory tract
infections. During inﬂuenza season 2008–2009, 116 oropharingeal swabs were collected from patients
affected by Inﬂuenza-Like Illness (ILI). The PCR products of hMPVM and HBoVNP-1 genes were sequenced. 78
out of 116 samples were positive for at least one respiratory virus; hBoV was detected in 53, hMPV in 22 and
InfA-B in 41 out of 116 swabs. A high rate of hBoV infection in adult (18.9%) and elderly (26.4%) subjects was
found. The co-infection rate was higher for hMPV (18/22 cases, 81.8%) compared to hBoV (26/53 cases, 49.1%),
and InfA-B (25/41 cases, 61.0%). Co-infections were common in children. hBoV positive samples shared a high
level of genetic similarity with the hBoV1 genotype, and hMPV positive samples clustered with A2 subgroup.
Our results suggest that hBoV and hMPV play a role in ILI.ido).
l rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
Acute respiratory tract infections (ARTI) associate with signiﬁcant
morbidity worldwide, especially in infants and children. Viruses are a
leading cause of ARTI, showing a relevant epidemiological variability
that depends on climate and region (Armstrong et al., 1999). Etiology
is still undeﬁned in a signiﬁcant proportion of ARTI (Monto, 1994;
Henrickson et al., 2004).
The impact of ARTI on health and disease is particularly difﬁcult to
address. Similar symptoms can be generated by a variety of agents
[inﬂuenza virus (Inf), human adenovirus, respiratory syncytial virus
(RSV)]. Moreover, respiratory tract samples from healthy subjects or
from patients without respiratory symptoms are rarely available.
Viruses, such as Inf, RSV, human adenovirus and coronaviruses
NL63 and HKU1 are known to be responsible for the most of
respiratory tract infections (Kesson, 2007). In a signiﬁcant proportion
of respiratory tract disease, however, no pathogens are identiﬁed.
During the past few years, new respiratory viruses have been
discovered. Today, human metapneumovirus (hMPV), family Para-
myxoviridae, is considered one of themost relevant agents of ARTI and
it has been reported worldwide (Van den Hoogen et al., 2001;
Debiaggi et al., 2006; Kahn, 2006; Sarasini et al., 2006; Boivin et al.,
2007).The hMPV has been associated with ARTI in all age groups, with
more severe disease occurring in young children, elderly individuals
and immunocompromised hosts. The virus causes a variety of clinical
syndromes in children that are typical of the paramyxoviruses,
including upper and lower respiratory tract illness. The clinical
characteristics of hMPV infections are not distinctive.
It has been reported that the epidemiological and clinical
characteristics of hMPV closely resemble those of RSV (Boivin et al.,
2002; Van den Hoogen et al., 2004).
Human bocavirus (hBoV) is a novel parvovirus, family Parvovi-
ridae, often associated with respiratory tract disease in adult and
pediatric patients worldwide. hBoV has been detected in serum and
fecal samples, predominantly in children under the age of 2 years with
respiratory infections (Lindner and Modrow, 2008). By means of both
genetic organization and sequence homology analyses relations to
members of the two genuses, bovine parvovirus and canine minute
virus, could be established. Consequently, hBoV has been classiﬁed as
a bocavirus (Allander et al., 2005).
Recently, three viruses closely related to hBoV have been reported,
provisionally named human bocavirus 2 (hBoV2), human bocavirus 3
(hBoV3), and human bocavirus 4 (hBoV4). It remains unclear whether
hBoV1, hBoV2, hBoV3, and hBoV4 represent unique viral entities or
distant genotypes of a single virus. However, it is a fact that hBoV1
infection has been linked with mild to severe lower respiratory tract
infection, but that it has also been detected at low frequency in stool
samples, while hBoV2, hBoV3 and hBoV4 have been detected in
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Kapoor et al., 2010).
The impact of hMPV and of hBoV on the global epidemiology of
ARTI is still unclear. In fact, most reports are retrospective (Peret et al.,
2002; Stockton et al., 2002) or predominantly focus on hospitalized
children and on children affected by ARTI (Maggi et al., 2003;
Wilkesmann et al., 2006; Wolf et al., 2006).
Epidemiological and clinical features of Inﬂuenza-like Illness (ILI) in
general population need to be highlighted and ongoing investigations
are necessary.We have studied the occurrence of hBoV, hMPV and Inf A
and Inf B (InfA-B) in an Apulian population with respiratory tract
infections.
Results
Prevalence of respiratory viruses
One hundred and sixteen patients (51.3%males, range 0–93 years)
with ILI were enrolled in the study.
The oro-pharyngeal swabs were collected from 52 children (aged
0–14 years), 22 youths and adults (15–64 years) and 42 elderly
subjects (≥64 years).
Seventy eight out of 116 samples (67.2%) analyzed by the
molecular method were positive for one or more respiratory viruses;
particularly, InfA-B was detected in 41 (35.3%), hMPV in 22 (19.0%)
and hBoV in 53 (45.7%) out of 116 oropharingeal swabs.
Single infection was found in 40.5% (n=47) and double infection
in 20.7% (n=24) of the subjects (Table 2).
The percentage of co-infections was higher for hMPV (18/22 cases,
81.8%; Pb0.05 vs. hBoV) compared to hBoV (26/53 cases, 49.1%), and to
InfA-B (25/41 cases, 61.0%). HBoV was detected mainly in association
with InfA-B (72.2%; 13/18). Seven triple infections (6%) were detected.
Age distribution
Viruses were detected only for the period between December and
Marchwith a peak on January, with a similar trend for the three viruses.Table 1
Flu A/B, hBoV and hMPV primers and thermal proﬁle used in viral genome ampliﬁcation.
Detection method Gene Primer sequences 5′-3′
hBoV
Nested-PCR NP-1 Boca-forward (B1f)
CCAGCAAGTCCTCCAAACT
Boca-reverse (B1r)
GGAGCTTCAGGATTGGAA
Nested-PCR NP-1 Boca-forward (B2f)
GAGCTCTGTAAGTACTATT
Boca-reverse (B2r)
CTCTGTGTTGACTGAATAC
hMPV
Nested-PCR M Meta-forward (M1f)
GAGTCCTAYCTRGTAGACA
Meta-reverse (M1r)
AGTACAGACATDGCWGCA
Nested-PCR M Meta- forward (M2f)
CAGCWGCTGTTCAAGTTG
Meta-reverse (M2r)
YTGTGATGYAGCATACAGA
Flu A/B multiplex real time PCR
FluA M GAGTCTTCTAACMGAGGT
GGGCACGGTGAGCGTRAA
FAM-TCCTGTCACCTCTGA
FluB M TAGCAGAAGGCCATGAAA
CGTTCCTAGTTTTACTTGCA
JOE-TGTCTCATGGTCATGThMPV exhibited a lower level of viral circulation than the other two
viruses (Fig. 1). The distribution of viruses in the age groups showed an
increased presence of infections in children (0–14 age group) followed
by elderly. In the 0–14 and 15–64 age groups, infections due to hBoV
were signiﬁcantly more represented than those due to hMPV (Pb0.05).
In the elderly (≥64 years), infections due to hMPV were signiﬁcantly
lower than those due to InfA-B (Pb0.05) and to hBoV (Pb0.01)
(Table 2).
Only for hMPV, the distribution was similar in the 15–64 and ≥64
age group. All triple infections were found in children (0–14 years),
while 54.2% of double infections were among children, 25.0% in the
15–64 age group and the remaining 20.8% in elderly.
Phylogenetic analysis
The hMPV M gene and hBoV NP1 gene from 13 samples were
ampliﬁed and sequenced. The phylogenetic analysis of the hBoV
nucleotide sequences revealed that all hBoV strains clustered with the
hBoV1 (NC_007455) genotype (identity range 75.0–100%) (Fig. 2). The
hMPV strains belonged to the A2 subgroup (identity range 74.0–97.0%)
(Fig. 3).
Discussion
We have designed a prospective study with the aim of describing
the virological impact of three different respiratory viruses (hMPV,
hBoV and InfA-B virus) in subjects with ILI in an Apulian population.
At least one out of the three viruses was identiﬁed in 67.2% of
patients, conﬁrming the widespread distribution in the population
(Calvo et al., 2010). hBoV was the most prevalent virus (45.7% of
cases), followed by InfA-B virus (35.3%) and hMPV (19.0%). Thus, our
results are consistent with data from other groups that attested the
presence of at least one of the potential viral pathogens in a 34% to 95%
of cases (Allander et al., 2007; Khetsuriani et al., 2007; Kusel et al.,
2007; Gendrel et al., 2007; García-García et al., 2010).
The viruses started spreading during late autumn, with a peak on
January; the prevalence of hMPV was lower than the other twoLocation Thermal proﬁle
95 °C 5′ (×1)
CACCTGC 162–187 95 °C 30″, 63 °C 30″
72 °C 30″ (×35)
GCTCTGTG 536–561 72 °C 7′ (×1)
95 °C 5′ (×1)
AC 188–208 95 °C 30″, 54 °C 30″
72 °C 30″ (×35)
AG 522–542 72 °C 7′ (×1)
95 °C 5′ (×1)
CC3 4–24 95 °C 1′, 55 °C 1′
72 °C 1′ (×25)
CC 232–251 72 °C 7′ (×1)
95 °C 5′ (×1)
44–61 95 °C 1′, 53 °C 1′
72 °C 1′ (×30)
G 175–195 72 °C 7′ (×1)
CGAAACGTA 13 FluAv_For
207 FluAv_Rev
C-MGB FluAv_TM
GCT 317 FluBv_For
TTGAAT 411 FluBv_Rev
ACCT-MGBNFQ FluBv_TM
Table 2
Distribution of hBoV, hMPV, and InfA-B of single and co-infections in subjects with ILI (n=116) by age.
InfA/B
n (%)
hMPV
n (%)
hBoV
n (%)
Total
n (%)
P value
Flu A/B vs hMPV Flu A/B vs hBoV hMPV vs hBoV
Age
0–14 (yrs) 21 (51.2) 16 (72.7) 29 (54.7) 52 (44.8) 0.4126 0.1695 0.0175
15–64 (yrs) 8 (19.5) 3 (13.6) 10 (18.9) 22 (19.0) 0.1623 0.7591 0.0452
N64 (yrs) 12 (29.3) 3 (13.6) 14 (26.4) 42 (36.2) 0.0204 0.8134 0.0055
Total 41 (35.3) 22 (19.0) 53 (45.7)
Single and co-infections
Total 41 (35.3) 22 (19.0) 53 (45.7) – 0.0079 0.1413 0.0001
Single infections 16 (39.0) 4 (18.2) 27 (50.9) 47 (40.5) 0.1547 0.3464 0.0104
Double infections 18 (43.9) 11 (50.0) 19 (35.8) 24 (20.7) 0.0902 0.2500 0.0104
Flu A/B – 5 (45.5) 13 (68.4) – – – –
hMPV 5 (27.8) – 6 (31.6) – – – –
hBoV 13 (72.2) 6 (54.5) – – – – –
Triple infections 7 (17.1) 7 (31.8) 7 (13.2) – – – –
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were effectively collected by the sentinel physicians only in the period
between on October and on March. This short time collection may
have limited the evaluation of the real time distribution of the viruses.
In order to assess the real viral seasonality, oropharyngeal swabs
should have been collected along a 12 month time period for at least
three consecutive years. It is natural, then, to assess that further
studies need to be performed in order to establish whether there is a
real epidemiological trend.
The frequency of respiratory viruses was higher in the 0–14 age
group, where the rate of viral detection reached 75.0%. hBoV was
detected in 45.7% (53/116 samples) of all the analyzed subjects and in
55.8% (29/52) of the children, a rate higher than previously reported
(Maggi et al., 2007). However, these results are not fully comparable
because of the different study design. In fact, none of the previous
studies was prospective; moreover, one of these studies included only
hospitalized children and showed differences in the rate of hBoV
detection during a period of years (Maggi et al., 2007).
Recent analyses documented the detection of hBoV also in
asymptomatic subjects, which suggests that the virus is not a true
pathogen but rather a commensal (Blessing et al., 2009; Salmón-
Mulanovich et al., 2011). However, although not yet completely
demonstrated, hBoV appears to contribute to the severity of respiratory
illness (Martin et al., 2010). In this study, a limitation is the lack of
control groups without clinical evidences of illness. To assess the real
role of this virus in respiratory infections, it would therefore be useful toFig. 1. Number of human bocavirus (hBoV), human metapneumovirus (hMPV) and
Inﬂuenza A–B virus per month.compare a symptomatic group with a control group and an asymptom-
atic period with a symptomatic period.
Phylogenetic analysis of the hBoV positive specimen sequences
revealed that all samples clustered in genotype hBoV1 NP1. Consistent
with other reports, strains of hBoV1 were more frequently identiﬁed in
respiratory swabs (Allander et al., 2005; Hishinuma-Igarashi et al.,
2009). However, due to the limited number of specimens the presence
in the patients of different hBoV genotypes cannot be excluded.
Among the emerging respiratory viruses, hMPV is one of the most
frequently reported in recent international studies (Van den Hoogen
et al., 2001; Boivin et al., 2007). In Italy, hMPV has been variously
associated with Upper Respiratory Tract Infections (URTI) or Lower
Respiratory Tract Infections (LRTI), affecting from 3% to 13% of children
withARTI (Bosis et al., 2005; Gerna et al., 2005; Sarasini et al., 2006). Our
data do not appear to be in agreement with previous reports, revealing
hMPV in 19.0% (22/116) of all samples and in particular in 30.8% (16/52)
of children. This virus was detected also in children older than 5 years,
which is not in agreement to other serological surveys that showed an
early acquisition of infection (Van den Hoogen et al., 2001; Zappa et al.,
2011). Nonetheless, hMPV is an emerging cause of ARTI in ILI patients
and may have a signiﬁcant clinical impact, especially in children.
With respect to others, a limitation of this study is the search of only
three respiratory viruses. Further studies should include human
parainﬂuenza viruses 1–3 (hPIVs), RSV, adenovirus for a more in
depth investigation. Furthermore, in this study the respiratory
infectionswere analyzed for only 1 year and the sampleswere collected
with limited information on the severity of clinical symptoms.
Phylogenetic analysis of hMPV strains in different countries has been
based on the comparison of sequences of L, N, F, or P genes (Van den
Hoogen et al., 2001, 2004a; Boivin et al., 2002, 2004; Bastien et al., 2003;
Mackay et al., 2004). In the present study, the RT-PCR was designed for
the M gene to detect hMPV with an equivalent sensitivity for both
genotypes. Recent studies have validated the use of the M gene (Bellau-
Pujol et al., 2005; Chano et al., 2005) and a genetic discrimination has
been established (Van den Hoogen et al., 2001; Bastien et al., 2003;
Carr et al., 2005; Legrandet al., 2011). In our study, phylogenetic analysis
of theM gene showed that the isolated viruses clusteredwith A2 strains.
Nevertheless, different hMPV genotypes and their sublineages can co-
circulate during the year and one of these can be prevalent (Huck et al.,
2006; Caracciolo et al., 2008; Xiao et al., 2010; Legrand et al., 2011).
The strains circulating in Italy were described in several studies
previously (Sarasini et al., 2006; Gerna et al., 2007; Caracciolo et al.,
2008; Larcher et al., 2008; Bosis et al., 2008; Zappa et al., 2011). In all
these studies, co-circulation of different hMPV genotypes was
observed, but A2 subtype was the most prominent strain. In our
study, it has not been possible to assess sub-division of A2 samples in
Fig. 2. A dendogram of human and animal BoV based on the NP-1 gene sequences from
representative pediatric and adult isolates originating from South Apulia using a 354 pb
region of the bocavirus NP-1 region. Additional strains of hBoV [NC_007455;
GU563338; FJ767757; GU563333; DQ513330; FJ156727; EF686010], hBoV2
[NC_0012042], hBoV3 [NC_0012564] and the animal parvoviruses: Canine Minute
Virus [NC_004442; Region 2389–2949] and Bovine Parvovirus [DQ335247; Region
2659–3300] are included.
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length analyzed in our experimental set up.
Our epidemiological ﬁndings support previous observations that
demonstrate an increase in A2 strain infections in recent years (Boivin
et al., 2004; Wang et al., 2008; Herbert et al., 2005; Zappa et al., 2011).
Other authors observed a shift from group A to group B (Agapov et al.,
2006; Mackay et al., 2006; Oliveira et al., 2009; Legrand et al., 2011).
Taken together, these data suggest a constant genetic evolution of
hMPV, which can play a role in the development of severe clinical
manifestations.
Simultaneous infections by different viruses have been well
documented (Choi et al., 2006; Kaida et al., 2007). In this study, viral
co-infections were detected in 26.7% of the cases. This rate is in
accordance with the previously published data implicating the rate of
dual and multiple infections to vary between 5% and 47.6% of all viral
respiratory infections (Aberle et al., 2005; Legg et al., 2005; Calvo et al.,
2010; Franz et al., 2010;Wang et al., 2010). It is possible that therewere
additional co-infections not detected in our study since we did not test
our respiratory samples for other probable pathogens such as
rhinovirus, human polyomaviruses, RSV and enteroviruses. In this
respect, this study should be considered preliminary to further
evaluation of other viruses causing respiratory co-infections.
The multiple co-infections and viral genotypes may aggravate the
severity of clinical disease in patients suffering from a respiratory
infection. However, data in the literature on both hBoV and hMPV
provide a mixed message, as some authors show a higher severity of
illness (Greensill et al., 2003; Semple et al., 2005), not observed in other
studies (Lazar et al., 2004; Williams et al., 2004; Bosis et al., 2005;
Caracciolo et al., 2008). In this study, the clinical picture induced by
co-infections was not more severe than that observed in patients with
only one viral infection. Further studies are needed to clarify thepathogenesis and interactions of co-infectants. When a single sample
contains many viruses it becomes difﬁcult to evaluate the clinical
signiﬁcance of each virus. In these cases, quantitative analysis of each
virus could be useful to provide information about the role of each
species on the severity of disease. The analysis of oropharingeal swabs is
methodologically difﬁcult because the quality of the specimens is
dependent on sampling technique and condition of the pharyngeal
mucosa. Therefore, an exact quantitation may be difﬁcult to obtain.
Our results suggest thathBoVandhMPVmaybepartially responsible
for the development of ILI in adult and elderly patients. hMPV is one of
the leading causes of infection in all of age groups, even in adulthood.
hMPV infection induces incomplete immunity, and reinfections later in
life are well documented, which justiﬁes the presence of hMPV among
adults of all ages (Falsey et al., 2003; Sloots et al., 2006; Walsh et al.,
2008), whereas hBoV is rarely detected in adults with respiratory
infections (Longtin et al., 2008). In most of the papers, isolated cases or
low incidence rates in adults were found. Often, this virus was detected
in at high risk or immunocompromised patients (Müller et al., 2009;
Ringshausen et al., 2009; Costa et al., 2009). Thus, our results are
unexpected forwhat regards the circulationof the analyzedviruses in all
of the age groups and the high hBoV infection rate in adult (18.9%) and
elderly (26.4%) subjects. Currently, there are no data that endogenous
reactivations or exogenous reinfections do occur for hBoV. So we
speculate that the high infection rate in adults could be due to a hBoV
secondary infection.
In conclusion, our results provide convincing evidence that in the
most of cases of ILI, hBoV and hMPV are involved. Thus, these
emergent viral pathogens should be carefully included in routine
testing in adult patients with atypical pneumonia but further studies
are necessary to prove the clinical relevance of such infections in
adults, especially for hBoV. In fact, there is growing consensus on the
existence of a relationship between hBoV infections and ARTI,
although high rates of co-infections with other respiratory viruses
have been reported (Boivin et al., 2007). Additional studies are
needed to understand the clinical and epidemiological signiﬁcance of
each virus involved in the co-infections.Materials and methods
Study population
In a time period between June 2008 andMay 2009, 116 oropharingeal
swabs were taken from patients with ILI, and demographic and clinical
data were collected. Sample collection was carried out by the Italian
Network for surveillance of Inﬂuenza (InﬂuNet) organized by the Italian
National Institute of Health (ISS) and the Inter-University Centre for
Research on Inﬂuenza (CIRI) in collaboration with the Regional Health
Authorities. Informed consent was obtained from the enrolled patient or
from their parents. The main clinical features were acute respiratory
problems with rapid and sudden onset with a temperature of N38 °C
accompanied by general symptoms (headache, feeling poorly, sweating,
asthenia, shivers) and by at least one respiratory symptom (cough,
pharyngodinia, nasal congestion) or fever accompanied by rhinitis,
rhinopharyngitis, tonsillitis, laryngeal tracheitis, tracheitis and acute
bronchitis. The collected samples were stored at−80 °C until processed.
Respiratory specimens were tested for hMPV, hBoV and InfA-B by
polymerase chain reaction (PCR) or reverse transcriptase-PCR (RT-PCR).RNA and DNA extraction
Isolation of viral RNA and DNA, from 250 to 400 μl samples,
respectively, was performed using Rneasy Mini Kit and QIAamp DNA
MiniKit (Qiagen GmbH, Hilden, Germany) according to the manufac-
turer's instructions.
Fig. 3. A dendogram of hMPV based on the M gene sequences from representative pediatric and adult isolates originating from South Apulia using a 151 pb region of the MPVM region.
The gene bank access numbers of the referenced strains are: A1 [AF371337, HQ384159, HQ384156, HQ384126, HQ384125, HQ384124, AJ145294], A2 [AJ530095, AJ297749],
B1 [HQ384134, HQ384140, HQ384152, HQ384151, HQ384145, HQ384135, HQ384142, HQ384139, AJ525843], and B2 [AJ297748, HQ384157, HQ384146, HQ384150, HQ384154].
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hMPV and InfA-B detection was performed by RT-nested-PCR and
hBoV detection by nested-PCR. For reverse transcription, a commercial
kit (RevertAidTM First Strand cDNA Synthesis kit, Fermentas Life
Sciences) was used. A subsequent nested PCRwas carried out using 5 μl
of the ﬁrst reaction product, which was then added to the reaction
mixture to a ﬁnal volume of 50 μl.
RT-nested-PCRwas designed to amplify the conserved region of the
hMPV matrix gene corresponding to matrix protein; nested-PCR was
performed by using portions of the hBoV NP-1 gene as primers targets.
Primer sequences, target genes and thermal proﬁles are reported in
Table 1.
Sequencing and phylogenetic analysis
The PCR products of hMPVM gene (nt 44–61, corresponding to a 151
base-pairs fragment) and hBoVNP-1 gene (nt 108–208, corresponding to
354 base-pairs fragment) were puriﬁed with QIAamp nucleic acid
puriﬁcation kits (Qiagen, Germany), according to the manufacturer'sprotocol. PCR products were sequenced directly or after cloning using the
CEQ 8000 (Beckman Coulter) automated sequencer, with the same
forwardprimers (M2f andB2f; see Table 1) used for the PCR. Phylogenetic
afﬁliation of the obtained sequences was determined by using the BLAST
search tool at the NCBI web site. Sequence similarity was searched by
BLAST (www.ncbi.nlm.nih.gov/blast). Multiple sequence alignment was
conducted with ClustalW2 version 2.1 (www.ebi.ac.uk/clustalw) and
phylogenetic trees were constructed by the Neighbor-Joining method
and Kimura 2-Parameter model using Molecular Evolutionary Genetics
Analysis (MEGA) software version 5.0 (www.xmegasoftware.net).
A bootstrap resampling analysis was performed (1000 replicates) to
test tree robustness. This analysis was performed on hMPV matrix
nucleotide sequences and on a portion of the hBoV NP-1 nucleotide
sequences.
Statistical analysis
Statistical analysis was performed with StatView 5.1 Software.
Categorical variables between groups were compared with the Fisher's
Exact-test. Pb0.05 was considered to be statistically signiﬁcant.
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